For more information click to follow.

For more information, please visit:This communication expressly or implicitly contains certain forward-looking statements concerning Intercell AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors that lead to the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Intercell AG is providing this communication as of this date does not undertake any forward-looking statements contained herein as a result of new information, future events or otherwise update click to follow .

About Intercell AGIntercell AG is a growing biotechnology company that designs and develops novel vaccines for the prevention and treatment of infectious diseases with significant unmet medical needs. Intercell’s vaccine to prevent Japanese Encephalitis is the first product on the market.

Source: Andrew Lavin United States Associates.